Free Trial
NYSEAMERICAN:MAIA

MAIA Biotechnology (MAIA) Stock Price, News & Analysis

MAIA Biotechnology logo
$1.65 +0.11 (+7.14%)
Closing price 04:10 PM Eastern
Extended Trading
$1.68 +0.03 (+1.52%)
As of 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MAIA Biotechnology Stock (NYSEAMERICAN:MAIA)

Key Stats

Today's Range
$1.62
$1.75
50-Day Range
$1.48
$2.01
52-Week Range
$1.40
$3.74
Volume
1.98 million shs
Average Volume
333,605 shs
Market Capitalization
$54.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MAIA Biotechnology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

MAIA MarketRank™: 

MAIA Biotechnology scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for MAIA Biotechnology.

  • Earnings Growth

    Earnings for MAIA Biotechnology are expected to decrease in the coming year, from ($1.30) to ($1.35) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MAIA Biotechnology is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MAIA Biotechnology is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MAIA Biotechnology has a P/B Ratio of 14.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MAIA Biotechnology's valuation and earnings.
  • Percentage of Shares Shorted

    3.25% of the float of MAIA Biotechnology has been sold short.
  • Short Interest Ratio / Days to Cover

    MAIA Biotechnology has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MAIA Biotechnology has recently increased by 75.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MAIA Biotechnology does not currently pay a dividend.

  • Dividend Growth

    MAIA Biotechnology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.25% of the float of MAIA Biotechnology has been sold short.
  • Short Interest Ratio / Days to Cover

    MAIA Biotechnology has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MAIA Biotechnology has recently increased by 75.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MAIA Biotechnology has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for MAIA Biotechnology this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for MAIA on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added MAIA Biotechnology to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MAIA Biotechnology insiders have bought more of their company's stock than they have sold. Specifically, they have bought $50,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    32.32% of the stock of MAIA Biotechnology is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.65% of the stock of MAIA Biotechnology is held by institutions.

  • Read more about MAIA Biotechnology's insider trading history.
Receive MAIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MAIA Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MAIA Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel
See More Headlines

MAIA Stock Analysis - Frequently Asked Questions

MAIA Biotechnology's stock was trading at $2.09 at the beginning of the year. Since then, MAIA stock has decreased by 18.9% and is now trading at $1.6950.

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) released its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.21.

Top institutional investors of MAIA Biotechnology include Centric Wealth Management (1.89%), Geode Capital Management LLC (0.73%), Jane Street Group LLC (0.09%) and Marshall Wace LLP (0.05%). Insiders that own company stock include Stan Smith, Ngar Yee Louie, Vlad Vitoc, Cristian Luput, Ramiro Guerrero and Joseph F Mcguire.
View institutional ownership trends
.

Shares of MAIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MAIA Biotechnology investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL), Adobe (ADBE) and AppLovin (APP).

Company Calendar

Last Earnings
11/12/2024
Today
8/27/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:MAIA
CIK
1878313
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.25 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-497.29%
Return on Assets
-165.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.19
Quick Ratio
2.19

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.12 per share
Price / Book
14.13

Miscellaneous

Outstanding Shares
32,990,000
Free Float
22,330,000
Market Cap
$55.92 million
Optionable
Not Optionable
Beta
0.01
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSEAMERICAN:MAIA) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners